Bio Similars & Subsequent Entry Biologic market: Forecasts on Production, Consumption, and Sales | Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries

"
The Bio Similars & Subsequent Entry Biologic global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors. Readers can enhance their knowledge on the trading strategies, recent developments, current and future progress of the key players in the Bio Similars & Subsequent Entry Biologic global market.

The report includes an in-depth study of the global market segment Bio Similars & Subsequent Entry Biologic, where segments and sub-segments are analyzed in quite detail. This research will help players focus on high growth segments and modify their business strategy, if needed. The Bio Similars & Subsequent Entry Biologic global market is segmented based on type, application and geography. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, China, Europe, India , US, UK and MEA. Our researchers and analysts use reliable primary and secondary sources for research and data.

Major Players : Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee

Request a sample of the report at : https://www.qyresearch.com/sample-form/form/5096048/Global-Bio-Similars-Subsequent-Entry-Biologic-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Companies-Key-Regions-Types-and-Application

Global Bio Similars & Subsequent Entry Biologic Market Types: Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other

Global Bio Similars & Subsequent Entry Biologic Market Applications: Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Study Coverage: This section includes brief information about key products sold in the global Bio Similars & Subsequent Entry Biologic market followed by an overview of important segments and manufacturers covered in the report. It also gives highlights of market size growth rates of different type and application segments. Furthermore, it includes information about study objectives and years considered for the complete research study.

Executive Summary: Here, the report focuses on key trends of various products and other markets. It also shares analysis of the competitive landscape, where prominent players and market concentration ratio are shed light upon. Prominent players are studied on the basis of their date of market entry, products, manufacturing base distribution, and headquarters.

Market Size by Manufacturer: In this part of the report, expansion plans, mergers and acquisitions, and price, revenue, and production by manufacturer are analyzed. This section also provides revenue and production shares by manufacturer.

Production by Region: Apart from global production and revenue shares by region, the authors have shared critical information about regional production in different geographical markets. Each regional market is analyzed taking into account vital factors, viz. import and export, key players, and revenue, besides production.

Consumption by Region: The report concentrates on global and regional consumption here. It provides figures related to global consumption by region such as consumption market share. All of the regional markets studied are assessed on the basis of consumption by country and application followed by analysis of country-level markets.

Market Size by Type: It includes analysis of price, revenue, and production by type.

Market Size by Application: It gives an overview of market size analysis by application followed by analysis of consumption market share, consumption, and breakdown data by application.

Key Industry Players: Leading players of the industry are profiled here on the basis of economic activity and plans, SWOT analysis, products, revenue, production, and other company details.

Entry Strategy for Key Countries: Entry strategies for all of the country-level markets studied in the report are provided here.

Production Forecasts: Apart from global production and revenue forecasts, this section provides production and revenue forecasts by region. It also includes forecast of key producers, where important regions and countries are taken into consideration, followed by forecast by type.

Consumption Forecast: It includes global consumption forecast by application and region. In addition, it provides consumption forecast for all regional markets studied in the report.

Opportunities and Challenges, Threats, and Affecting Factors: It includes Porter's Five Forces analysis, market challenges, opportunities, and other market dynamics.

Key Findings of the Study: These give a clear picture of the current and future status of the global Bio Similars & Subsequent Entry Biologic market.

Request for customization in Report: https://www.qyresearch.com/customize-request/form/5096048/Global-Bio-Similars-Subsequent-Entry-Biologic-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Companies-Key-Regions-Types-and-Application

Table of Contents:

1 Market Overview of Bio Similars & Subsequent Entry Biologic
1.1 Bio Similars & Subsequent Entry Biologic Market Overview
1.1.1 Bio Similars & Subsequent Entry Biologic Product Scope
1.1.2 Bio Similars & Subsequent Entry Biologic Market Status and Outlook
1.2 Global Bio Similars & Subsequent Entry Biologic Market Size Overview by Region 2017 VS 2021 VS 2028
1.3 Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2017-2028)
1.4 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Region (2017-2022)
1.5 Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Region (2023-2028)
1.6 Key Regions, Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
1.6.1 North America Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
1.6.2 Europe Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
1.6.3 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
1.6.4 Latin America Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
1.6.5 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
2 Bio Similars & Subsequent Entry Biologic Market Overview by Type
2.1 Global Bio Similars & Subsequent Entry Biologic Market Size by Type: 2017 VS 2021 VS 2028
2.2 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Type (2017-2022)
2.3 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2023-2028)
2.4 Monoclonal Antibodies
2.5 Interferon
2.6 Erythropoietin
2.7 Insulin
2.8 Vaccines
2.9 Other
3 Bio Similars & Subsequent Entry Biologic Market Overview by Application
3.1 Global Bio Similars & Subsequent Entry Biologic Market Size by Application: 2017 VS 2021 VS 2028
3.2 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Application (2017-2022)
3.3 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2023-2028)
3.4 Tumor
3.5 Diabetes
3.6 Cardiovascular
3.7 Hemophilia
3.8 Other
4 Bio Similars & Subsequent Entry Biologic Competition Analysis by Players
4.1 Global Bio Similars & Subsequent Entry Biologic Market Size by Players (2017-2022)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2021)
4.3 Date of Key Players Enter into Bio Similars & Subsequent Entry Biologic Market
4.4 Global Top Players Bio Similars & Subsequent Entry Biologic Headquarters and Area Served
4.5 Key Players Bio Similars & Subsequent Entry Biologic Product Solution and Service
4.6 Competitive Status
4.6.1 Bio Similars & Subsequent Entry Biologic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Sun Pharma
5.1.1 Sun Pharma Profile
5.1.2 Sun Pharma Main Business
5.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.1.4 Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.1.5 Sun Pharma Recent Developments
5.2 Synthon Pharmaceuticals
5.2.1 Synthon Pharmaceuticals Profile
5.2.2 Synthon Pharmaceuticals Main Business
5.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.2.4 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.2.5 Synthon Pharmaceuticals Recent Developments
5.3 Teva Pharmaceutical Industries
5.3.1 Teva Pharmaceutical Industries Profile
5.3.2 Teva Pharmaceutical Industries Main Business
5.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.3.4 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.3.5 LG Life Sciences Recent Developments
5.4 LG Life Sciences
5.4.1 LG Life Sciences Profile
5.4.2 LG Life Sciences Main Business
5.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.4.4 LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.4.5 LG Life Sciences Recent Developments
5.5 Celltrion Biocon
5.5.1 Celltrion Biocon Profile
5.5.2 Celltrion Biocon Main Business
5.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.5.4 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.5.5 Celltrion Biocon Recent Developments
5.6 Hospira
5.6.1 Hospira Profile
5.6.2 Hospira Main Business
5.6.3 Hospira Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.6.4 Hospira Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.6.5 Hospira Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.7.4 Merck Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.7.5 Merck Recent Developments
5.8 Biogen idec
5.8.1 Biogen idec Profile
5.8.2 Biogen idec Main Business
5.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.8.4 Biogen idec Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.8.5 Biogen idec Recent Developments
5.9 Genentech (Roche)
5.9.1 Genentech (Roche) Profile
5.9.2 Genentech (Roche) Main Business
5.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.9.4 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.9.5 Genentech (Roche) Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.10.4 Pfizer Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.10.5 Pfizer Recent Developments
5.11 Celltrion
5.11.1 Celltrion Profile
5.11.2 Celltrion Main Business
5.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.11.4 Celltrion Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.11.5 Celltrion Recent Developments
5.12 Biocon
5.12.1 Biocon Profile
5.12.2 Biocon Main Business
5.12.3 Biocon Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.12.4 Biocon Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.12.5 Biocon Recent Developments
5.13 Amgen
5.13.1 Amgen Profile
5.13.2 Amgen Main Business
5.13.3 Amgen Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.13.4 Amgen Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.13.5 Amgen Recent Developments
5.14 Samsung Biologics
5.14.1 Samsung Biologics Profile
5.14.2 Samsung Biologics Main Business
5.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.14.4 Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.14.5 Samsung Biologics Recent Developments
5.15 Mylan
5.15.1 Mylan Profile
5.15.2 Mylan Main Business
5.15.3 Mylan Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.15.4 Mylan Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.15.5 Mylan Recent Developments
5.16 Dr. Reddy's Laboratories
5.16.1 Dr. Reddy's Laboratories Profile
5.16.2 Dr. Reddy's Laboratories Main Business
5.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.16.4 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.16.5 Dr. Reddy's Laboratories Recent Developments
5.17 Stada Arzneimittel AG
5.17.1 Stada Arzneimittel AG Profile
5.17.2 Stada Arzneimittel AG Main Business
5.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.17.4 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.17.5 Stada Arzneimittel AG Recent Developments
5.18 AbbVie
5.18.1 AbbVie Profile
5.18.2 AbbVie Main Business
5.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.18.4 AbbVie Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.18.5 AbbVie Recent Developments
5.19 Sanofi-Aventis
5.19.1 Sanofi-Aventis Profile
5.19.2 Sanofi-Aventis Main Business
5.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.19.4 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.19.5 Sanofi-Aventis Recent Developments
5.20 Johnson & Johnson
5.20.1 Johnson & Johnson Profile
5.20.2 Johnson & Johnson Main Business
5.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.20.4 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.20.5 Johnson & Johnson Recent Developments
5.21 Novo Nordisk
5.21.1 Novo Nordisk Profile
5.21.2 Novo Nordisk Main Business
5.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.21.4 Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.21.5 Novo Nordisk Recent Developments
5.22 Eli Lilly
5.22.1 Eli Lilly Profile
5.22.2 Eli Lilly Main Business
5.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.22.4 Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.22.5 Eli Lilly Recent Developments
5.23 Novartis
5.23.1 Novartis Profile
5.23.2 Novartis Main Business
5.23.3 Novartis Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.23.4 Novartis Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.23.5 Novartis Recent Developments
5.24 3sbio
5.24.1 3sbio Profile
5.24.2 3sbio Main Business
5.24.3 3sbio Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.24.4 3sbio Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.24.5 3sbio Recent Developments
5.25 Biotech
5.25.1 Biotech Profile
5.25.2 Biotech Main Business
5.25.3 Biotech Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.25.4 Biotech Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.25.5 Biotech Recent Developments
5.26 Gelgen
5.26.1 Gelgen Profile
5.26.2 Gelgen Main Business
5.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.26.4 Gelgen Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.26.5 Gelgen Recent Developments
5.27 Innovent
5.27.1 Innovent Profile
5.27.2 Innovent Main Business
5.27.3 Innovent Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.27.4 Innovent Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.27.5 Innovent Recent Developments
5.28 Dong Bao
5.28.1 Dong Bao Profile
5.28.2 Dong Bao Main Business
5.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.28.4 Dong Bao Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.28.5 Dong Bao Recent Developments
5.29 Ganlee
5.29.1 Ganlee Profile
5.29.2 Ganlee Main Business
5.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Products, Services and Solutions
5.29.4 Ganlee Bio Similars & Subsequent Entry Biologic Revenue (US$ Million) & (2017-2022)
5.29.5 Ganlee Recent Developments
6 North America
6.1 North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2017-2028)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2017-2028)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2017-2028)
8.2 China
8.3 Japan
8.4 South Korea
8.5 India
8.6 Australia
8.7 Taiwan
8.8 Indonesia
9 Latin America
9.1 Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2017-2028)
9.2 Mexico
9.3 Brazil
9.4 Argentina
10 Middle East & Africa
10.1 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2017-2028)
10.2 Turkey
10.3 Saudi Arabia
10.4 U.A.E
11 Bio Similars & Subsequent Entry Biologic Market Dynamics
11.1 Bio Similars & Subsequent Entry Biologic Industry Trends
11.2 Bio Similars & Subsequent Entry Biologic Market Drivers
11.3 Bio Similars & Subsequent Entry Biologic Market Challenges
11.4 Bio Similars & Subsequent Entry Biologic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Contact Us:
QY Research, INC.
17890 Castleton, Suite 369,
Los Angeles, CA - 91748
USA: +1 626 539 9760
India: +91 9766 478 224
Emails - enquiry@qyresearch.com
Web - www.qyresearch.com

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US:

QY RESEARCH, INC.

17890 CASTLETON STREET

SUITE 369, CITY OF INDUSTRY

CA - 91748, UNITED STATES OF AMERICA

+1 626 539 9760 / +91 8669986909

hitesh@qyresearch.com / enquiry@qyresearch.com"

This release was published on openPR.